CCX140-B

CCX140-B · Amgen

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for CCX140-B, covering 2023-12-05 to 2025-03-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes Mellitus [Phase 2]